Detalhe da pesquisa
1.
Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial.
Mov Disord
; 2024 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38850081
2.
Dopaminergic denervation using [123I]-FPCIT and pain in Parkinson's disease: a correlation study.
J Neural Transm (Vienna)
; 126(3): 279-287, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30706197
3.
Personality and quality-of-life improvement after apomorphine infusion in Parkinson's disease.
Brain Commun
; 6(3): fcae181, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38846534
4.
Personality assessment with Temperament and Character Inventory in Parkinson's disease.
Parkinsonism Relat Disord
; 103: 34-41, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030666
5.
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II).
J Parkinsons Dis
; 12(2): 699-711, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897100
6.
Personality dimensions of patients can change during the course of parkinson's disease.
PLoS One
; 16(1): e0245142, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33411732
7.
Personality Dimensions Are Associated with Quality of Life in Fluctuating Parkinson's Disease Patients (PSYCHO-STIM).
J Parkinsons Dis
; 10(3): 1057-1066, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32444557
8.
Discontinuation rate and long-term adverse events path of apomorphine infusion in advanced Parkinson's disease patients.
Parkinsonism Relat Disord
; 116: 105859, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37788512